New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

DexCom (NasdaqGS:DXCM) has begun a broad U.S. rollout of its G7 15-day continuous glucose monitoring system, extending sensor wear time for users. The company is preparing a nationwide release of ...

Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...

Dexcom's 2026 revenue estimates lagged analysts' expectations, according to data compiled by the London Stock Exchange Group (LSEG).

Analysts expect DexCom to report earnings of $0.6459 per share on revenue of $1.24 billion for the quarter ended December 2025. That would mark a sequential improvement from the third quarter’s $0.61 ...

The S&P 500 closed barely higher Feb. 13, with technology and communications services down on nagging fears of AI-disruption but equities drew support from optimism that cooling ...

Oura partners with femtech company Mira to integrate hormone testing data with wellness tracking, targeting the booming $60B ...

Ireland has reaffirmed its position as a leading global destination for foreign direct investment (FDI), with IDA Ireland receiving prominent recognition at the 2026 fDi Intelligence inaugural ...

Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. In ...

Meditation isn’t thinking about nothing. New research reinforces that it’s a mind-altering, dynamic state that promotes focus ...

According to preliminary data, the S&P 500 gained 2.32 points, or 0.03 per cent, to end at 6,835.08 points, while the Nasdaq Composite lost 52.04 points, or 0.2 per cent, to 22,545.11. The Dow Jones ...

Baxter International Inc. BAX is scheduled to release fourth-quarter 2025 results on Feb. 12, before the opening bell. In the ...